Iroko ships Vivlodex osteoarthritis drug
PHILADELPHIA — Iroko Pharmaceuticals LLC this week made Vivlodex, a nonsteroidal anti-inflammatory drug (NSAID) for osteoarthritis pain, available by prescription at pharmacies across the United States. Iroko said that a 12-week study Vivlodex delivered efficacy at low 5-mg and 10-mg doses in patients with osteoarthritis pain. The products dosage strengths (5 mg and 10 mg)
